1 |
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description [J]. Circulation, 2002, 106(24): 3006-3008.
|
2 |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines [J]. J Am Coll Cardiol, 2017, 70(2): 252-289.
|
3 |
Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology task force on clinical expert consensus documents [J]. J Am Coll Cardiol, 2017, 69(10): 1313-1346.
|
4 |
Frerker C, Baldus S, Nitschmann S. Transcatheter aortic valve replacement: PARTNER 3 trial and Evolut Low Risk Trial [J]. Internist (Berl), 2019, 60(11): 1221-1224.
|
5 |
Liu XB, Jiang JB, Zhou QJ, et al. Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenotic bicuspid aortic valve in a Chinese population [J]. J Zhejiang Univ Sci B, 2015, 16(3): 208-214.
|
6 |
Liao YB, Li YJ, Xiong TY, et al. Comparison of procedural, clinical and valve performance results of transcatheter aortic valve replacement in patients with bicuspid versus tricuspid aortic stenosis [J]. Int J Cardiol, 2018, 254: 69-74.
|
7 |
Zhou D, Pan W, Wang J, et al. VitaFlow™ transcatheter valve system in the treatment of severe aortic stenosis: one-year results of a multicenter study [J]. Catheter Cardiovasc Interv, 2020, 95(2): 332-338.
|
8 |
宋光远, 王墨扬, 王媛, 等. Venus-A主动脉瓣膜介入治疗重度主动脉瓣狭窄的效果 [J]. 中华心血管病杂志, 2017, 45(10): 843-847.
|
9 |
Hoffmeister KJ, Henderson ZT, Hussey PT, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a focused review for the cardiac anesthesiologist [J]. J Cardiothorac Vasc Anesth, 2020, 34(10): 2740-2753.
|
10 |
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation [J]. J Am Soc Echocardiogr, 2017, 30(4): 303-371.
|
11 |
Zoghbi WA, Asch FM, Bruce C, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement [J]. J Am Soc Echocardiogr, 2019, 32(4): 431-475.
|
12 |
Ayhan H, Kasapkara HA, Durmazt , et al. Impact of transcatheter aortic valve implantation in patients with reduced ejection fraction [J]. Cardiol J, 2015, 22(1): 108-114.
|
13 |
Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis [J]. J Am Coll Cardiol, 2004, 43(4): 698-703.
|
14 |
赵映, 李治安, 孙琳, 等. 斑点追踪技术评价重度主动脉瓣狭窄瓣膜置换术前后左室收缩功能 [J]. 中国超声医学杂志, 2011, 27(3): 224-227.
|
15 |
Jilaihawi H, Jeilan M, Spyt T, et al. Early regression of left ventricular wall thickness following percutaneous aortic valve replacement with the CoreValve bioprosthesis [J]. J Invasive Cardiol, 2009, 21(4): 151-155.
|
16 |
肖明虎, 吴永健, 王婧金, 等. 经导管主动脉瓣置换术后左心室的逆重构 [J]. 中国超声医学杂志, 2019, 35(11): 998-1000.
|
17 |
Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes [J]. Circulation, 2009, 119(23): 3009-3016.
|
18 |
Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement [J]. N Engl J Med, 2012, 366(18): 1686-1695.
|
19 |
Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry [J]. Heart, 2011, 97(11): 899-906.
|